TP53 and neoplasm: Immortalised clones derived from carcinogen-exposed primary Hupki mouse embryo fibroblasts (MEFs) harbour patterns of TP53 mutation that closely resemble those identified in human tumours from patients exposed to the same carcinogens (8–11).